Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1391 ARTÍCULOS , VIENDO DEL 1246 AL 1260

A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD)

Ballard C, Thomas A, Gerry S, Yu LM, Aarsland D, Merritt C, Corbett A, Davison C, Sharma N, Khan Z, Creese B, Loughlin P, Bannister C, Burns A, Win SN, Walker Z; MAIN-AD investigators.

J Am Med Dir Assoc. 2015 Apr;16(4):316-22. doi: 10.1016/j.jamda.2014.11.002. Epub 2014 Dec 15.

Working memory and language network dysfunctions in logopenic aphasia: a task-free fMRI comparison with Alzheimer's dementia

Whitwell JL, Jones DT, Duffy JR, Strand EA, Machulda MM, Przybelski SA, Vemuri P, Gregg BE, Gunter JL, Senjem ML, Petersen RC, Jack CR Jr, Josephs KA.

Neurobiol Aging. 2015 Mar;36(3):1245-52. doi: 10.1016/j.neurobiolaging.2014.12.013. Epub 2014 Dec 16.

Evaluation and management of the elderly patient presenting with cognitive complaints

Hildreth KL, Church S.

Med Clin North Am. 2015 Mar;99(2):311-35. doi: 10.1016/j.mcna.2014.11.006. Epub 2014 Dec 23.

Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease

Blennow K, Dubois B, Fagan AM, Lewczuk P, de Leon MJ, Hampel H.

Alzheimers Dement. 2015 Jan;11(1):58-69. doi: 10.1016/j.jalz.2014.02.004. Epub 2014 May 3.

APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis

Liu Y, Yu JT, Wang HF, Han PR, Tan CC, Wang C, Meng XF, Risacher SL, Saykin AJ, Tan L.

J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):127-34. doi: 10.1136/jnnp-2014-307719. Epub 2014 May 16.

ABCA7 in Alzheimer's Disease

Zhao QF, Yu JT, Tan MS, Tan L.

Mol Neurobiol. 2015;51(3):1008-16. doi: 10.1007/s12035-014-8759-9. Epub 2014 May 31.

Chromosomal DNA damage measured using the cytokinesis-block micronucleus cytome assay is significantly associated with cognitive impairment in South Australians

Lee SL, Thomas P, Hecker J, Faunt J, Fenech M.

Environ Mol Mutagen. 2015 Jan;56(1):32-40. doi: 10.1002/em.21890. Epub 2014 Aug 6.

Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study

Fiandaca MS, Kapogiannis D, Mapstone M, Boxer A, Eitan E, Schwartz JB, Abner EL, Petersen RC, Federoff HJ, Miller BL, Goetzl EJ.

Alzheimers Dement. 2015 Jun;11(6):600-7.e1. doi: 10.1016/j.jalz.2014.06.008. Epub 2014 Aug 15.

CD33 rs3865444 Polymorphism Contributes to Alzheimer's Disease Susceptibility in Chinese, European, and North American Populations

Li X, Shen N, Zhang S, Liu J, Jiang Q, Liao M, Feng R, Zhang L, Wang G, Ma G, Zhou H, Chen Z, Jiang Y, Zhao B, Li K, Liu G.

Mol Neurobiol. 2015 Aug;52(1):414-21. doi: 10.1007/s12035-014-8880-9. Epub 2014 Sep 4.

Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study

Chouraki V, Beiser A, Younkin L, Preis SR, Weinstein G, Hansson O, Skoog I, Lambert JC, Au R, Launer L, Wolf PA, Younkin S, Seshadri S.

Alzheimers Dement. 2015 Mar;11(3):249-57.e1. doi: 10.1016/j.jalz.2014.07.001. Epub 2014 Sep 10.

Comparison of MR-less PiB SUVR quantification methods

Bourgeat P, Villemagne VL, Dore V, Brown B, Macaulay SL, Martins R, Masters CL, Ames D, Ellis K, Rowe CC, Salvado O, Fripp J; AIBL Research Group.

Neurobiol Aging. 2015 Jan;36 Suppl 1:S159-66. doi: 10.1016/j.neurobiolaging.2014.04.033. Epub 2014 Aug 27.

Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research

O'Bryant SE, Gupta V, Henriksen K, Edwards M, Jeromin A, Lista S, Bazenet C, Soares H, Lovestone S, Hampel H, Montine T, Blennow K, Foroud T, Carrillo M, Graff-Radford N, Laske C, Breteler M, Shaw L, Trojanowski JQ, Schupf N, Rissman RA, Fagan AM, Oberoi P, Umek R, Weiner MW, Grammas P, Posner H, Martins R; STAR-B and BBBIG working groups.

Alzheimers Dement. 2015 May;11(5):549-60. doi: 10.1016/j.jalz.2014.08.099. Epub 2014 Oct 1.

Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials

Donohue MC, Moghadam SH, Roe AD, Sun CK, Edland SD, Thomas RG, Petersen RC, Sano M, Galasko D, Aisen PS, Rissman RA.

Alzheimers Dement. 2015 Sep;11(9):1069-79. doi: 10.1016/j.jalz.2014.07.156. Epub 2014 Oct 7.

Volatile organic compounds (VOCs) fingerprint of Alzheimer's disease

Mazzatenta A, Pokorski M, Sartucci F, Domenici L, Di Giulio C.

Respir Physiol Neurobiol. 2015 Apr;209:81-4. doi: 10.1016/j.resp.2014.10.001. Epub 2014 Oct 13.

DTI-MRI biomarkers in the search for normal pressure hydrocephalus aetiology: a review

Hoza D, Vlasák A, Hořínek D, Sameš M, Alfieri A.

Neurosurg Rev. 2015 Apr;38(2):239-44; discussion 244. doi: 10.1007/s10143-014-0584-0. Epub 2014 Oct 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias